CM
PMC

Castleark Management’s PharMerica Corporation PMC Stock Holding History

Castleark Management’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-215,339
Closed -$6.16M – 360
2014
Q2 		$6.16M Buy
+215,339
New +$5.99M 0.17% 141

Other funds holding PMC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCM
Munder Capital Management Birmingham, Michigan $13.4B AUM 18.35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Castleark Management's PMC Position: Q3 2014 in Review

Castleark Management sold out of PharMerica Corporation (PMC) in Q3 2014, closing a stake of 215,339 shares — an estimated $6.16M sold.

Castleark Management first reported a position in PMC in Q2 2014 and held it in 1 quarter. The position peaked at $6.16M in Q2 2014. 161 funds tracked by Wall St. Rank hold PMC as of Q3 2014.

  • Castleark Management reported no remaining PharMerica Corporation position as of Q3 2014 after selling out during the quarter.
  • Castleark Management sold 215,339 PharMerica Corporation shares in Q3 2014, an estimated $6.16M.
  • Castleark Management first reported a position in PharMerica Corporation in Q2 2014 and held it in 1 quarter.
  • Castleark Management's PharMerica Corporation position peaked at $6.16M in Q2 2014.
  • 161 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2014.

Based on Castleark Management's 13F filing for Q3 2014, filed 17 Nov 2014.